BioTech Pharma
HomeCatalogAfamelanotide
Afamelanotide research vial

2D Molecular Structure

Afamelanotide 2D molecular structure for compound 16154396
CID
16154396
Standard InChIKey
UAHFGYDRQSXQEB-LEBBXHLNSA-N
FDA UNII
QW68W3J66U
Residue Count
13 AA
Structural Modifications
  • N-terminal acetyl
  • C-terminal amide
  • [Nle4, D-Phe7] substitutions
cosmetic Research

Afamelanotide

Also known as: Melanotan I, Melanotan-1, [Nle4,D-Phe7]-α-MSH, NDP-MSH

Linear [Nle4,D-Phe7]-α-MSH analog and reference melanocortin agonist, studied in melanogenesis and photoprotection research.
CAS Number
75921-69-6
Molecular Formula
C78H111N21O19
Molecular Weight
1646.8 g/mol
Purity
Batch-specific
Form
Lyophilized powder
Enquiry Sizes
Research vial • Bulk / custom fill (quote required)
Peptide Sequence13 residues
Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2

Compliance Notice: All products supplied by BioTech Pharma are intended strictly for laboratory research and development use only. They are not intended for human or veterinary use, diagnosis, treatment, or consumption of any kind. By submitting an enquiry, the requester confirms they are a qualified researcher or institution and accepts full responsibility for compliant handling and use.

Configure Your Request

Documentation requests are reviewed against the records available for the applicable lot. Availability, methods, and values must be confirmed for the specific enquiry and are not promised in advance.

Form supplied: Lyophilized powder. Your selections are carried into the quote request automatically.

Overview

Afamelanotide (also called Melanotan I or NDP-MSH) is a linear tridecapeptide analog of α-MSH carrying norleucine at position 4 and D-phenylalanine at position 7. These substitutions markedly increase potency and metabolic stability relative to native α-MSH, making it one of the most extensively characterized melanocortin agonists in the literature.

As an established pharmacology, afamelanotide is a regulator-recognized active ingredient: it is the drug substance in an approved product for a specific inherited photosensitivity disorder. In a research setting it serves as a stable, high-affinity melanocortin reference compound for melanogenesis, MC1R signaling, and photoprotection studies — distinct from its clinical role, which BioTech Pharma does not address.

BioTech Pharma supplies afamelanotide as a lyophilized powder for in-vitro and preclinical research use only. It is not supplied for human, clinical, or veterinary use. Lot-specific analytical documentation may be available and should be confirmed for the applicable material.

Research Applications

  • MC1R signaling and melanogenesis models
  • Eumelanin synthesis in melanocyte culture
  • UV-photoprotection mechanism studies (in vitro)
  • Comparative melanocortin-agonist pharmacology

Frequently Asked Questions

Scientific References

Analytical Data

Lot-specific documentation may be available for the applicable material and must be confirmed per enquiry. Where available, it may include:

  • HPLC purity result
  • LC-MS identity confirmation
  • Appearance
  • Net content

Request the records you need with your quote and we will confirm availability for your batch.

Procurement Details

Availability, lead time, salt / content basis, and cold-chain requirements depend on the specific lot and quantity, so we confirm them per enquiry rather than publishing fixed figures. Request confirmation for your requirements with your quote and our team will respond with details for the applicable batch.

Storage & Handling

Lyophilized: store at −20 °C, protected from light and moisture. Reconstituted: store cold and protected from light; verify prepared-solution stability for the applicable material before extended use.

Related Compounds